Follow Our Live Coverage of COVID-19 Developments

Half-Price Version of Humalog Insulin Now Available

Eli Lilly's generic version being sold under the chemical name insulin lispro

Please note: This article was published more than one year ago. The facts and conclusions presented may have since changed and may no longer be accurate. And "More information" links may no longer work. Questions about personal health should always be referred to a physician or other health care professional.

WEDNESDAY, May 22, 2019 (HealthDay News) -- A half-price version of Humalog insulin is now available in the United States, Eli Lilly said Wednesday.

The company's generic version of its Humalog U-100 is being sold under the chemical name insulin lispro, the Associated Press reported. It will cost $137.35 per vial, or $265.20 for a package of five easier-to-inject KwikPens, according to Lilly. That is half the list price the company charges for Humalog.

Patients who will see the biggest savings with insulin lispro are those who do not have health insurance, have high-deductible insurance, or have Medicare Part D plans, according to Lilly.

Sharply rising insulin costs in the United States have sparked intense criticism. From 2002 through 2013, the average insulin price nearly tripled, and prices have increased 10 percent per year since then. Many patients with diabetes have been forced to ration their insulin, resulting in hospitalizations and some deaths, the AP reported.

AP News Article

Last Updated: